| Element List | Current Year | Previous Year | %Change | ||
|---|---|---|---|---|---|
| Sales/Revenue | 3,070,726,717 | 3,062,261,277 | 0.28 | ||
| Gross Profit (Loss) | 1,414,060,429 | 1,342,292,117 | 5.35 | ||
| Operational Profit (Loss) | 694,687,149 | 658,476,355 | 5.5 | ||
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 666,812,348 | 589,340,930 | 13.14 | ||
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 678,184,604 | 595,903,466 | 13.81 | ||
| Total Shareholders Equity (after Deducting Minority Equity) | 2,961,990,682 | 2,523,806,078 | 17.36 | ||
| Profit (Loss) per Share | 8.34 | 7.37 | |||
| All figures are in (Actual) Saudi Arabia, Riyals | |||||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| All figures are in (Actual) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| The reason of the increase (decrease) in the sales/ revenues during the current year compared to the last year | Revenue increases in general due to: - Increase in revenue in Pharmaceuticals segment While noting that there is Decrease in revenue in the following segments: a) Specialty chemical. b) Steel |
| The reason of the increase (decrease) in the net profit during the current year compared to the last year is | Net profit Increases in general due to: 1. Increase in Gross Profit in the following sector: a) Pharmaceuticals b) Steel segment. 2. Decrease in finance costs mainly in Specialty Chemical segment. 3. Share in profit from unconsolidated subsidiary While noting that there is gain from discontinued operation in similar period last year. |
| Statement of the type of external auditor's report | Unmodified opinion |
| Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) | N\A |
| Reclassification of Comparison Items | Certain comparative figures for the previous period have been reclassified to be consistent with the presentation of the current period. |
| Additional Information | Net Shareholders’ Equity at the end of the period was SR 2,961,482,209/- compared to SR 2,530,968,707/- at the end of the similar period last year with an increase of 17%. |
